
Earlier, Sun Pharma had paid interim dividend of ₹7 per share for the previous financial year 2021-22.
The deal will help gain access to Concert’s drug to treat baldness
SGX Nifty hints at a flat to positive start for Indian benchmark indices BSE Sensex and NSE Nifty 50. Mukesh…
The deal will enable the Indian company to advance its treatment of Alopecia Areata, a dermatological disease, which results in…
The health regulator inspected the manufacturing facility from April 26 to May 9, 2022.
In a statement, the company claimed that Sun Pharma transformed from a US$ 1.7 billion organisation focusing on India and…
Quarter performance beat estimates; FY23/24e EPS up 1/3%; target price revised to Rs 1,089; ‘Buy’ retained.
Sun Pharmaceutical Industries’ share price fell 3.5 per cent intraday on Monday, despite a 43 per cent on-year growth in…
Traction in specialty sales was maintained; FY23/24e EPS down 3.3/3.5%; ‘Buy’ retained with revised target price of Rs 1,040
Sun Pharmaceuticals share price fell 2% to hit an intraday low of Rs 856.7 on NSE on Tuesday after the…
Total loss cited as an exceptional item during the fourth quarter, stood at Rs 3,936 crore.
The company’s unit – SC Terapia SA, Romania – has acquired the Uractiv portfolio, which comprises food supplements, including minerals,…
A Form 483 is issued after completion of inspection of a facility and when the investigator has observed that may…
Sun Pharma on Tuesday said the US health regulator has issued a ‘Form 483’ with ten observations after inspecting its…
BSE Sensex and Nifty 50 were trading nearly half a per cent down on Monday, on the back of selling…
From the last four weeks, prices are trading between the ranges of 16800-17500 levels and whenever the prices dip near…
With earnings season winding down, investors will turn their attention back to macroeconomic concerns, with special focus on inflation numbers
Bulls were back in the seat as headline indices marked consecutive weekly gains with Nifty ending at 18255. Last week…
The 20 day SMA also continues to trade below the 50 day SMA, indicating a negative moving average crossover. Weekly…
BSE Sensex and Nifty 50 were trading at record high levels on Wednesday, on the back of buying in metal…
The market for nutrition bars in India is growing rapidly, with an increasing focus on fitness for a healthy lifestyle.
Commenting on the company’s Halol plant, which has been under the USFDA radar for the last few years, Shanghvi said…
Loading…
Something went wrong. Please refresh the page and/or try again.